News

Ibrahim “I-Bizzle” shows off his crib in Seattle Children’s teen and young adult cancer unit

Ibrahim “I-Bizzle” shows off his crib in Seattle Children’s teen and young adult cancer unit

Source: On the Pulse Blog

Eighteen-year-old Ibrahim El-Salaam, aka “I-Bizzle,” was born with a blood disorder called sickle cell disease and has been coming to Seattle Children’s Hospital for as long as he can remember. His disease has required him to spend a lot of time in the Inpatient Cancer Unit at Seattle Children’s, which houses patients who require inpatient stays for both cancer and blood disorders. When he’s there, he likes to find fun ways to pass the time – like making an “MTV Cribs”-inspired video to show off his pad in the country’s first Adolescent and Young Adult (AYA) Cancer Unit, which opened last year.

About Seattle Children’s

Seattle Children’s mission is to provide hope, care and cures to help every child live the healthiest and most fulfilling life possible. Together, Seattle Children’s Hospital, Research Institute and Foundation deliver superior patient care, identify new discoveries and treatments through pediatric research, and raise funds to create better futures for patients.

Ranked as one of the top children’s hospitals in the country by U.S. News & World Report, Seattle Children’s serves as the pediatric and adolescent academic medical center for Washington, Alaska, Montana and Idaho – the largest region of any children’s hospital in the country. As one of the nation's top five pediatric research centers, Seattle Children’s Research Institute is internationally recognized for its work in neurosciences, immunology, cancer, infectious disease, injury prevention and much more. Seattle Children’s Hospital and Research Foundation works with the Seattle Children’s Guild Association, the largest all-volunteer fundraising network for any hospital in the country, to gather community support and raise funds for uncompensated care and research.

For more information, visit seattlechildrens.org or follow us on Twitter, Facebook, Instagram or on our On the Pulse blog.